Oxidative stress-related genotypes, fruit and vegetable consumption and breast cancer risk

Carcinogenesis

Volumn 30, Issue 5, 2009, Pages 777-784

  Li, Yulin ^a   Ambrosone, Christine B ^a   Mccullough, Marjorie J ^b   Ahn, Jiyoung ^c   Stevens, Victoria I ^b   Thun, Michael J ^b   Hong, Chi Chen ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b AMERICAN CANCER SOCIETY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CATALASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEME OXYGENASE 1; MYELOPEROXIDASE;

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FRUIT; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL ASSESSMENT; OXIDATIVE STRESS; POSTMENOPAUSE; PRIORITY JOURNAL; VEGETABLE;

ANTIOXIDANTS; BREAST NEOPLASMS; CATALASE; COHORT STUDIES; DIET; FEMALE; FRUIT; GENOTYPE; HEME OXYGENASE-1; HUMANS; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PEROXIDASE; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; RISK FACTORS; UNITED STATES; VEGETABLES;

EID: 65549089566     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp053     Document Type: Article

References (84)

1. Halliwell,B. et al. (eds) (1999) Free Radicals in Biology and Medicine. Oxford University Press, New York.
2. Ambrosone,C.B. (2000) Oxidants and antioxidants in breast cancer. Antioxid. Redox Signal., 2, 903-917.
3. Michels,K.B. et al. (2007) Diet and breast cancer: A review of the prospective observational studies. Cancer, 109, 2712-2749.
4. Fund WCR. (1997) Food, Nutrition and the Prevention of Cancer. A Global Perspective. American Institute for Cancer Research, Washington, DC.
5. Cui,Y. et al. (2008) Selected antioxidants and risk of hormone receptor-defined invasive breast cancers among postmenopausal women in the Women's Health Initiative Observational Study. Am. J. Clin. Nutr. 87, 1009-1018.
6. Gaudet,M.M. et al. (2004) Fruits, vegetables, and micronutrients in relation to breast cancer modified by menopause and hormone receptor status. Cancer Epidemiol. Biomarkers Prev., 13, 1485-1494.
7. Giles,G.I. (2006) The redox regulation of thiol dependent signaling pathways in cancer. Curr. Pharm. Des., 12, 4427-4443.
8. Ryter,S.W. et al. (2005) Heme oxygenase-1: Redox regulation of a stress protein in lung and cell culture models. Antioxid. Redox Signal., 7, 80-91.
9. Ahn,J. et al. (2006) Associations between catalase phenotype and genotype: Modification by epidemiologic factors. Cancer Epidemiol. Biomarkers Prev., 15, 1217-1222.
10. Ahn,J. et al. (2005) Associations between breast cancer risk and the catalase genotype, fruit and vegetable consumption, and supplement use. Am. J. Epidemiol., 162, 943-952.
11. Klebanoff,S.J. (1999) Myeloperoxidase. Proc. Assoc. Am. Physicians 111, 383-389.
12. Piedrafita,F.J. et al. (1996) An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J. Biol. Chem., 271, 14412-14420.
13. Feyler,A. et al. (2002) Point: Myeloperoxidase -463G ← a polymorphism and lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 11, 1550-1554.
14. London,S.J. et al. (1997) Myeloperoxidase genetic polymorphism and lung cancer risk. Cancer Res., 57, 5001-5003.
15. Schabath,M.B. et al. (2000) Genetic variants of myeloperoxidase and lung cancer risk. Carcinogenesis, 21, 1163-1166.
16. Ahn,J. et al. (2004) Myeloperoxidase genotype, fruit and vegetable consumption, and breast cancer risk. Cancer Res., 64, 7634-7639.
17. Zhen,J. et al. (2008) Upregulation of endothelial and inducible nitric oxide synthase expression by reactive oxygen species. Am. J. Hypertens., 21, 28-34.
18. Fukumura,D. et al. (2006) The role of nitric oxide in tumour progression. Nat. Rev. Cancer, 6, 521-534.
19. Hofseth,L.J. et al. (2003) Nitric oxide in cancer and chemoprevention. Free Radic. Biol. Med., 34, 955-968.
20. Hussain,S.P. et al. (2004) Nitric oxide, a mediator of inflammation, suppresses tumorigenesis. Cancer Res., 64, 6849-6853.
21. Ying,L. et al. (2007) An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer. Cancer Res., 67, 1407-1410.
22. Tesauro,M. et al. (2000) Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: Cleavage of proteins with aspartate vs. glutamate at position 298. Proc. Natl Acad. Sci. USA, 97, 2832-2835.
23. Veldman,B.A. et al. (2002) The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J. Hypertens., 20, 2023-2027.
24. Ahsan,A. et al. (2005) Simultaneous selection of the wild-type genotypes of the G894T and 4B/4A polymorphisms of NOS3 associate with high-altitude adaptation. Ann. Hum. Genet., 69, 260-267.
25. Hefler,L.A. et al. (2006) Polymorphisms of the endothelial nitric oxide synthase gene in breast cancer. Breast Cancer Res. Treat., 98, 151-155.
26. Hong,C.C. et al. (2007) Genetic variability in iron-related oxidative stress pathways (Nrf2, NQ01, NOS3, and HO-1), iron intake, and risk of postmenopausal breast cancer. Cancer Epidemiol. Biomarkers Prev., 16, 1784-1794.
27. Lee,K.M. et al. (2007) Genetic polymorphisms of NOS3 are associated with the risk of invasive breast cancer with lymph node involvement. Breast Cancer Res. Treat., 106, 433-438.
28. Lu,J. et al. (2006) Promoter polymorphism (-786t>C) in the endothelial nitric oxide synthase gene is associated with risk of sporadic breast cancer in non-Hispanic white women age younger than 55 years. Cancer, 107, 2245-2253.
29. Royo,J.L. et al. (2006) Lack of association between NOS3 Glu298Asp and breast cancer risk: A case-control study. Breast Cancer Res. Treat., 100, 331-333.
30. Schneider,B.P. et al. (2008) Association of polymorphisms of angiogenesis genes with breast cancer. Breast Cancer Res. Treat., 111, 157-163.
31. Yang,J. et al. (2007) Relationships between polymorphisms in NOS3 and MPO genes, cigarette smoking and risk of post-menopausal breast cancer. Carcinogenesis, 28, 1247-1253.
32. Maines,M.D. (1988) Heme oxygenase: Function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J., 2, 2557-2568.
33. Kimpara,T. et al. (1997) Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease. Hum. Genet., 100 145-147.
34. Yamada,N. et al. (2000) Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am. J. Hum. Genet., 66, 187-195.
35. Chang,K.W. et al. (2004) Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers. Br. J. Cancer, 91, 1551-1555.
36. Kikuchi,A. et al. (2005) Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-1 gene promoter polymorphism. Hum. Genet., 116, 354-360.
37. Lo,S.S. et al. (2007) Heme oxygenase-1 gene promoter polymorphism is associated with risk of gastric adenocarcinoma and lymphovascular tumor invasion. Ann. Surg. Oncol., 14, 2250-2256.
38. Chen,Y.H. et al. (2002) Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum. Genet., 111 1-8.
39. Okamoto,I. et al. (2006) A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with risk for melanoma. Int. J. Cancer, 119, 1312-1315.
40. Calle,E.E. et al. (2002) The American Cancer Society Cancer Prevention Study II Nutrition Cohort: Rationale, study design, and baseline characteristics. Cancer, 94, 2490-2501.
41. Rothman,K.J. et al. (1998) Modern Epidemiology. Lippincott-Raven, Philadelphia, PA.
42. Block,G. et al. (1990) A reduced dietary questionnaire: development and validation. Epidemiology, 58-64.
43. U.S. Department of Agriculture, Agricultural Research Service, Beltsville Human Nutrition Research Center, Food Surveys Research Group (Beltsville, MD). Continuing Survey of Food Intakes by Individuals 1994-96, 1998 and Diet and Health Knowledge Survey 1994-96: Documentation (csfii9498_ documentationupdated.pdf) or Data Files (csfii9498⊣ta.exe). Food Surveys Research Group.
44. Block,G. et al. (1989) Habits and History Questionnaire: Diet History and Other Risk Factors. Division of Cancer Prevention and Control, National Cancer Institute, National Institute of Health, Bethesda, MD.
45. Flagg,E.W. et al. (2000) Validation of the American Cancer Society Cancer Prevention Study II nutrition survey cohort food frequency questionnaire. Epidemiology, 11, 462-468.
46. He,C. et al. (2009) A prospective study of genetic polymorphism in MPO, antioxidant status, and breast cancer risk. Breast Cancer Res. Treat., 113, 585-594.
47. Uitterlinden,A.G. et al. (2005) Genetic vitamin D receptor polymorphisms and risk of disease. In Feldman,D., Pike,J.W. and Glorieux,F.H. (eds.) Vitamin D. Elsevier Academic Press, Burlington, MA.
48. Fulle,S. et al. (2005) Age-dependent imbalance of the antioxidative system in human satellite cells. Exp. Gerontol., 40, 189-197.
49. Tatone,C. et al. (2006) Age-dependent changes in the expression of superoxide dismutases and catalase are associated with ultrastructural modifications in human granulosa cells. Mol. Hum. Reprod., 12 655-660.
50. Cao,L. et al. (2004) Aging alters the functional expression of enzymatic and non-enzymatic anti-oxidant defense systems in testicular rat Leydig cells. J. Steroid Biochem. Mol. Biol., 88, 61-67.
51. Borras,C. et al. (2005) 17Beta-oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2[MAPK]/NFkappaB cascade. Aging Cell, 4, 113-118.
52. Dabrosin,C. et al. (1998) Impact of oestradiol and progesterone on antioxidant activity in normal human breast epithelial cells in culture. Free Radic. Res., 28, 241-249.
53. Mobley,J.A. et al. (2004) Estrogen receptor-mediated regulation of oxidative stress and DNA damage in breast cancer. Carcinogenesis, 25, 3-9.
54. Roy,D. et al. (1989) Changes in activities of free radical detoxifying enzymes in kidneys of male Syrian hamsters treated with estradiol. Cancer Res., 49, 1475-1480.
55. Bekesi,G. et al. (2001) Induced myeloperoxidase activity and related superoxide inhibition during hormone replacement therapy. BJOG, 108, 474-481.
56. Reynolds,W.F. et al. (1999) Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease. Exp. Neurol., 155, 31-41.
57. Loibl,S. et al. (2006) Investigations on the inducible and endothelial nitric oxide synthases in human breast cancer cell line MCF-7-estrogen has an influence on e-NOS, but not on i-NOS. Pathol. Res. Pract., 202, 1-7.
58. Nakatani,K. et al. (2004) Expression of endothelial nitric oxide synthase is induced by estrogen with glycogen synthase 3beta phosphorylation in MCF-7 cells. Oncol. Rep., 12, 833-836.
59. Simoncini,T. et al. (2003) Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms. Endocrinology, 144, 3449-3455.
60. Yallampalli,C. et al. (2000) Estradiol-17beta inhibits nitric oxide synthase (NOS)-II and stimulates NOS-III gene expression in the rat uterus. Biol. Reprod., 63, 34-41.
61. Cascorbi,I. et al. (2000) Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant-463A of the myeloperoxidase gene. Cancer Res., 60, 644-649.
62. Hung,R.J. et al. (2004) Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk. Carcinogenesis, 25, 973-978.
63. Le Marchand,L. et al. (2000) Association of the myeloperoxidase -463G→a polymorphism with lung cancer risk. Cancer Epidemiol. Biomarkers Prev., 9, 181-184.
64. Misra,R.R. et al. (2001) Variation in the promoter region of the myeloperoxidase gene is not directly related to lung cancer risk among male smokers in Finland. Cancer Lett., 164, 161-167.
65. Xu,L.L. et al. (2002) Counterpoint: The myeloperoxidase -463G→a polymorphism does not decrease lung cancer susceptibility in Caucasians. Cancer Epidemiol. Biomarkers Prev., 11, 1555-1559.
66. Roy,D. et al. (2007) Estrogen-induced generation of reactive oxygen and nitrogen species, gene damage, and estrogen-dependent cancers. J. Toxicol. Environ. Health B Crit. Rev., 10, 235-257.
67. Pance,A. (2006) Nitric oxide and hormones in breast cancer: Allies or enemies? Future Oncol., 2, 275-288.
68. Benito,S. et al. (2002) A flavonoid-rich diet increases nitric oxide production in rat aorta. Br. J. Pharmacol., 135, 910-916.
69. McCarty,M.F. (2008) Scavenging of peroxynitrite-derived radicals by flavonoids may support endothelial NO synthase activity, contributing to the vascular protection associated with high fruit and vegetable intakes. Med. Hypotheses, 70, 170-181.
70. Ambs,S. et al. (1997) Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J., 11, 443-448.
71. Wink,D.A. et al. (1991) DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science, 254, 1001-1003.
72. Shen,Y.H. et al. (1998) Nitric oxide induces and inhibits apoptosis through different pathways. FEBS Lett., 433, 125-131.
73. Wink,D.A. et al. (1996) The effect of various nitric oxide-donor agents on hydrogen peroxide-mediated toxicity: A direct correlation between nitric oxide formation and protection. Arch. Biochem. Biophys., 331, 241-248.
74. Alvarez,S. et al. (2002) Polyphenols and red wine as peroxynitrite scavengers: A chemiluminescent assay. Ann. N. Y. Acad. Sci., 957, 271-273.
75. Klotz,L.O. et al. (2003) Defenses against peroxynitrite: selenocompounds and flavonoids. Toxicol. Lett., 140-141, 125-132.
76. Yokozawa,T. et al. (2003) Protective activity of (-)-epicatechin 3-O-gallate against peroxynitrite-mediated renal damage. Free Radic. Res., 37, 561-571.
77. Wippel,R. et al. (2004) Interference of the polyphenol epicatechin with the biological chemistry of nitric oxide- and peroxynitrite-mediated reactions. Biochem. Pharmacol., 67, 1285-1295.
78. Cornblatt,B.S. et al. (2007) Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast. Carcinogenesis, 28, 1485-1490.
79. Joung,E.J. et al. (2007) Capsaicin induces heme oxygenase-1 expression in HepG2 cells via activation of PI3K-Nrf2 signaling: NAD(P)H:qUinone oxidoreductase as a potential target. Antioxid. Redox Signal., 9, 2087-2098.
80. Kweon,M.H. et al. (2006) Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate. J. Biol. Chem. 281, 33761-33772.
81. Motterlini,R. et al. (2000) Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic. Biol. Med. 28, 1303-1312.
82. Ogborne,R.M. et al. (2004) Haem oxygenase-1: A target for dietary antioxidants. Biochem. Soc. Trans., 32, 1003-1005.
83. Guenegou,A. et al. (2008) Interaction between a heme oxygenase-1 gene promoter polymorphism and serum beta-carotene levels on 8-year lung function decline in a general population: The European Community Respiratory Health Survey (France). Am. J. Epidemiol., 167, 139-144.
84. Jensen,O.M. et al. (1984) The reliability of questionnaire-derived historical dietary information and temporal stability of food habits in individuals. Am. J. Epidemiol., 120, 281-290.